Children to no longer receive puberty blockers at gender identity clinics, NHS says

Get the free Morning Headlines e mail for information from our reporters the world over

Sign up to our free Morning Headlines e mail

Children will no longer be prescribed puberty blockers at gender identity clinics, NHS England has confirmed.

Puberty blockers, which pause the bodily modifications of puberty akin to breast improvement or facial hair, will now solely be out there to youngsters as a part of medical analysis trials.

Fewer than 100 younger individuals are presently on puberty blockers and they are going to be ready to proceed their therapy. These youngsters are being seen by specialist endocrine providers at Leeds and University College London Hospital.

The choice comes after a public session on the problem and an NHS England-commissioned impartial assessment in 2020 of gender identity providers for youngsters beneath 18.

That assessment, led by Dr Hilary Cass, adopted an increase in referrals to the Gender Identity Development Service (Gids) run by the Tavistock and Portman NHS Foundation Trust.

In the yr to April 2022, there have been over 5,000 referrals to Gids, in contrast to slightly below 250 a decade earlier.

The clinic has come beneath repeated scrutiny and is closing at the top of March.

Following the Tavistock’s closure, two new NHS providers will open in early April, in London’s Great Ormond Street Hospital and Alder Hey Children’s Hospital in Liverpool.

In February 2022, Dr Cass revealed an interim report saying there was a necessity to transfer away from one unit and beneficial the creation of regional providers to higher help children.

The NHS has stated youngsters attending these clinics shall be supported by medical consultants in neurodiversity, paediatrics and psychological well being, “resulting in a holistic approach to care”.

Around 250 sufferers are anticipated to be transferred to the brand new clinics from Gids once they open and a few 5,000 extra youngsters and younger individuals are presently on the ready checklist for referral into the brand new clinics.

Dr Cass additionally pointed to an absence of long-term proof and knowledge assortment on what occurs to youngsters and younger people who find themselves prescribed medicine.

She added that Gids had not collected routine and constant knowledge “which means it is not possible to accurately track the outcomes and pathways that children and young people take through the service”.

Health minister Maria Caulfield stated: “We have always been clear that children’s safety and wellbeing is paramount, so we welcome this landmark decision by the NHS.

“Ending the routine prescription of puberty blockers will help ensure that care is based on evidence, expert clinical opinion and is in the best interests of the child.”

The session on the way forward for providers acquired greater than 4,000 responses, together with round 1 / 4 from members of the general public, 22 per cent from sufferers, 21 per cent from dad and mom, 10 per cent from trans adults and 5 per cent from clinicians.

John Stewart, nationwide director of specialized commissioning at NHS England, instructed the PA information company: “Given that the debate is often very polarised, so too were the responses to the consultation.

“Many people said the policy didn’t go far enough in terms of still allowing potential access [to puberty blockers] through research, and others saying clearly they disagreed fundamentally and that these should be routinely available to everyone who believes they need it.”

Regarding the brand new clinics, he stated: “This is just the first step in building a regional model, where our aim is to establish between seven and eight specialist centres, including the north and the south hubs, over the next year to two years.”

It is known NHS England hopes to have a examine into using puberty blockers in place by December 2024, with eligibility standards but to be determined.